Patent Assignment
Reel/Frame 044822/0624
Assignment of Assignor's Interest
Recorded: 2018-02-02
Pages: 8
Assignors
LIU, SHUANG
Executed: 2013-07-12
DUFFY, BRYAN CORDELL
Executed: 2013-07-12
WANG, RUIFANG
Executed: 2013-07-12
JIANG, MAY XIAOWU
Executed: 2013-07-12
MARTIN, GREGORY SCOTT
Executed: 2013-07-12
QUINN, JOHN FREDERICK
Executed: 2013-07-09
ZHAO, HE
Executed: 2013-07-12
ELLIS, MICHAEL
Executed: 2013-07-12
WAGNER, GREGORY STEVEN
Executed: 2013-07-26
YOUNG, PETER RONALD
Executed: 2013-07-10
Assignee
RVX THERAPEUTICS INC.
279 MIDPARK WAY SE, CALGARY, AB, T2X 1M2, CANADA
Covered Property
(1)
Novel Substituted Bicyclic Compounds as Bromodomain Inhibitors
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 2, 2018
From: LIU, SHUANG; QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; WANG, RUIFANG
To: ZENITH EPIGENETICS CORP.
Reel/Frame 045243/0809 →
Change of Name
Feb 2, 2018
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 045243/0816 →
Assignment of Assignor's Interest
Feb 2, 2018
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 045243/0819 →
General Conveyance and Assumption Agreement
Feb 2, 2018
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP.
Reel/Frame 045254/0058 →